LY6S
Lymphocyte antigen 6S
Also known as: LY6S_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- P0DTL4
- Gene
- LY6S
- Canonical length
- 134 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for LY6S in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
134 residues, UniProt reviewed canonical sequence.
>P0DTL4|LY6S
1 MSSLQAMKTL SLVLLVALLS MERAQGLRCY RCLAVLEGAS CSVVSCPFLD GVCVSQKVSV
61 FGSKVRGENK LSLLSCQKDV GFPLLKLTSA VVDSQISCCK GDLCNAVVLA ASSPWALCVQ
121 LLLSLGSVFL WALLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LY6S can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 1.7 nTPM
Expression across tissuesHPA
Tissue
- spleen: 1.7 nTPM
- adrenal gland: 1.5 nTPM
- gallbladder: 1.2 nTPM
- thyroid gland: 1.2 nTPM
- cerebral cortex: 0.9 nTPM
- endometrium: 0.7 nTPM
Single-cell type
- late spermatids: 2.5 nCPM
- early spermatids: 0.6 nCPM
- late primary spermatocytes: 0.6 nCPM
- cardiomyocytes: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- intermediate monocyte: 0.4 nTPM
- classical monocyte: 0.2 nTPM
- memory B-cell: 0.2 nTPM
- myeloid DC: 0.2 nTPM
- NK-cell: 0.2 nTPM
- non-classical monocyte: 0.2 nTPM
Brain region
- thalamus: 9.1 nTPM
- cerebral cortex: 8 nTPM
- cerebellum: 6.4 nTPM
- midbrain: 6.1 nTPM
- basal ganglia: 5.5 nTPM
- hypothalamus: 5.5 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LY6S as an antibody target. Whether an autoantibody or antibody against LY6S could matter depends on whether native LY6S is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LY6S is annotated at the cell surface, where native LY6S is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LY6S as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...